Dr. Martin Fensch leads Governmental Affairs & Strategic Partnerships Europe/Canada at Daiichi-Sankyo, a pharmaceutical company headquartered in Japan. The company has a large manufacturing site in Bavaria, Germany, and specialises in innovative medicines for Oncology and Cardiovascular disease. With roots in journalism and over 18 years of experience in the pharmaceutical industry, Martin’s focus is on building teams and external relationships while fostering a culture of diversity and trust. Prior to joining Daiichi-Sankyo in 2022, he held various national and international leadership roles at Pfizer — in the areas of Policy, Communications, and Business. Martin served as Managing Director in the German Pfizer-Organization for 10 years and holds a doctorate in philosophy. In 2022, he published the book “News and Fake News on Vaccination” and periodically teaches Public Relations at the ESCP Business School. Martin is an active member of the Stiftung Überleben” and "Vision Zero in Oncology" advisory boards.
Updated: September 2023